Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With Human Immunodeficiency Virus Infected
Latest Information Update: 05 Oct 2023
At a glance
- Drugs Coronavirus vaccine-Wuhan Institute of Biological Products (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Sponsors China National Biotec Group
- 11 Nov 2021 New trial record